So far, CBS has cost subscribers $5.99 a month and still featured commercials. But that may not be the future of CBS All Access. Hereâs what CBS CEO Les Moonves had to say about the change the company would like to bring to CBS All Access moving forward. The big change? No commercials. At an investor conference in San Francisco, CBS CEO Les Moonves says the company wants to heavily push CBS All Access during the coming year.
Lantus | insulin glargine [rDNA origin] injection side effects and adverse reactions include: 1  Allergic reaction. 2  Hypoglycemia. 3  Discomfort at the injection site.
Demonstrated long-term CV safety. LantusÂ® is a basal insulin with demonstrated long-term CV safety dataâ â . View the data. LantusÂ® is a long-acting insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. LantusÂ® should be administered once a day at the same time every day.